CQPTY News and Press, Collplant Holdings From 08/25/22

CollPlant Biotechnologies Provides Business Updates and Second Quarter 2022 Financial Results PR Newswire Co-development of rhCollagen-based dermal and soft tissue fillers with AbbVie is progressing Company's 3D bioprinted regenerative breast implant program remain...

CollPlant to Present and Exhibit at TERMIS Annual Conference in Toronto, Canada PR Newswire At the Tissue Engineering and Regenerative Medicine International Society conference, CollPlant will deliver a presentation ' rhCollagen - The Ideal Building Block For 3D ...

CollPlant Biotechnologies Provides Business Updates and First Quarter 2022 Financial Results PR Newswire Co-development of rhCollagen-based dermal and soft tissue filler products with AbbVie is advancing according to plan Launch of large animal study for Comp...

CollPlant CEO Yehiel Tal to Moderate ISBF's virtual event on Biofabrication of Microphysiological Systems for Drug Discovery and Screening PR Newswire REHOVOT, Israel , April 25, 2022 /PRNewswire/ -- CollPlant (Nasdaq: CLGN), a regenerative and a...

CollPlant To Present at the Aesthetics Innovation Summit 2022 PR Newswire REHOVOT, Israel , April 13, 2022 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products fo...

CollPlant Biotechnologies Provides Business Updates and Fiscal Year 2021 Financial Results - Record revenues in 2021 of $15.6 million versus $6.1 million in 2020 - Continued progress of strategic agreement with AbbVie to develop dermal and soft tissue filler products using C...

CELLINK and CollPlant Enter a Collaboration Agreement to Explore Future Large-Scale Production of CollPlant's Regenerative Breast Implants using CELLINK's Bioprinting technologies CollPlant and CELLINK will explore the use of CELLINK's next-generation high throughput extrusion b...

CollPlant Announces Publication Highlighting its rhCollagen-based Photocurable Dermal Filler in the Plastic and Reconstructive Surgery Journal PR Newswire Preclinical modeling demonstrates potential for filler to enhance cell proliferation and new tissue regeneration f...

CollPlant Biotechnologies Provides Business Updates and Third Quarter 2021 Financial Results Company launches rhCollagen-based BioInk platform with Collink.3D™ for use in 3D bioprinting of human tissues, scaffolds and organs PR Newswire REHOVOT, Israel , ...

CollPlant Announces Commercial Launch of BioInk Platform with Collink.3D™ for Use in 3D Bioprinting of Human Tissues, Scaffolds and Organs rhCollagen-based BioInk provides biopharma and academia with attractive alternative to tissue extracted collagen for use in new produ...